Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents

被引：0
|
作者：
Binder, Moritz [1 ]
Rajkumar, S. Vincent [2 ]
Ketterling, Rhett P. [3 ]
Dispenzieri, Angela [2 ]
Lacy, Martha Q. [2 ]
Gertz, Morie A. [2 ]
Buadi, Francis K. [2 ]
Hayman, Suzanne R. [2 ]
Hwa, Yi L. [2 ]
Zeldenrust, Steven R. [2 ]
Lust, John A. [2 ]
Russell, Stephen J. [2 ]
Leung, Nelson [2 ]
Kapoor, Prashant [2 ]
Go, Ronald S. [2 ]
Gonsalves, Wilson I. [2 ]
Kyle, Robert A. [2 ]
Kumar, Shaji K. [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3255.3255
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3255
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [2] Substratification of patients with newly diagnosed standard-risk multiple myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 254 - 260
  • [3] Circulating Plasma Cells in Newly Diagnosed Symptomatic Multiple Myeloma As a Prognostic Marker for Patients with Standard-Risk Cytogenetics
    Vagnoni, Davide
    Travaglini, Fosco
    Angelini, Stefano
    Dalsass, Alessia
    Mestichelli, Francesca
    Angelini, Mario
    Pezzoni, Valerio
    Natale, Annalisa
    Ruggieri, Miriana
    Bigazzi, Catia
    Troiani, Emanuela
    Falcioni, Sadia
    Mazzotta, Serena
    Galieni, Piero
    BLOOD, 2014, 124 (21)
  • [4] Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics
    Vagnoni, Davide
    Travaglini, Fosco
    Pezzoni, Valerio
    Ruggieri, Miriana
    Bigazzi, Catia
    Dalsass, Alessia
    Mestichelli, Francesca
    Troiani, Emanuela
    Falcioni, Sadia
    Mazzotta, Serena
    Natale, Annalisa
    Angelini, Mario
    Ferretti, Silvia
    Angelini, Stefano
    Galieni, Piero
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (04) : 523 - 531
  • [5] PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA AND STANDARD-RISK CYTOGENETICS
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    HAEMATOLOGICA, 2016, 101 : 263 - 264
  • [6] Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies
    Charalampous, Charalampos
    Goel, Utkarsh
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie
    Gertz, Morie
    Gonsalves, Wilson
    Hayman, Suzanne
    Hobbs, Miriam
    Hwa, Yi Lisa
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, Vincent
    Kumar, Shaji K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (10): : E329 - E335
  • [7] Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
    Zhang, Yue
    Chen, Xiao-Lei
    Chen, Wen-Ming
    Zhou, He-Bing
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [8] Risk of Early Severe Infections in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Agents: A Pooled Analysis
    Bonello, Francesca
    D'Agostino, Mattia
    Offidani, Massimo
    Petrucci, Maria Teresa
    Liberati, Anna Marina
    Patriarca, Francesca
    Capra, Andrea
    Benevolo, Giulia
    Gaidano, Gianluca
    Barila, Gregorio
    Galli, Monica
    Ponticelli, Elena
    Cascavilla, Nicola
    Angelucci, Emanuele
    Ballanti, Stelvio
    Pietrantuono, Giuseppe
    Pulini, Stefano
    Derudas, Daniele
    de Fabritiis, Paolo
    Corradini, Paolo
    Conticello, Concetta
    Cavo, Michele
    Sonneveld, Pieter
    Boccadoro, Mario
    Bringhen, Sara
    BLOOD, 2020, 136
  • [9] Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma
    Mellors, Patrick
    Binder, Moritz
    Ketterling, Rhett P.
    Griepp, Patricia
    Baughn, Linda B.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Haymann, Suzanne
    Kapoor, Prashant
    Gonsalves, Wilson I.
    Hwa, Yi Lisa
    Fonder, Amie
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Lust, John A.
    Leung, Nelson
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD, 2019, 134
  • [10] Amplification of Chromosome 1q Predicts Poor Overall Survival in Newly Diagnosed Multiple Myeloma Patients
    Skerget, Matevz
    Skopec, Barbara
    Zver, Samo
    Podgornik, Helena
    JOURNAL OF HEMATOLOGY, 2023, 12 (03) : 109 - 113
12345